Björn Papke

8PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 21, 2025
Unlocking RAS: Finding the Right Combination Is the Key.

Bjoern Papke, Channing J Der

|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp

|Dec 18, 2021
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.

Clint A Stalnecker, Kajal R Grover, A Cole Edwards

|Jun 03, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Kirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni

|Oct 26, 2019
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.

G Aaron Hobbs, Nicole M Baker, Anne M Miermont

Pageof 2